Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Operations Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 368.45%
Jun 30, 2025 125.08%
Mar 31, 2025 122.21%
Dec 31, 2024 172.68%
Sep 30, 2024 55.19%
Jun 30, 2024 -101.82%
Mar 31, 2024 -156.35%
Dec 31, 2023 60.01%
Sep 30, 2023 -85.76%
Jun 30, 2023 -16,906.67%
Mar 31, 2023 -123.61%
Dec 31, 2022 -640.90%
Sep 30, 2022 -122.89%
Jun 30, 2022 -99.33%
Mar 31, 2022 23.18%
Dec 31, 2021 -53.82%
Sep 30, 2021 -1,204.23%
Jun 30, 2021 955.87%
Mar 31, 2021 26.94%
Dec 31, 2020 1,390.14%
Sep 30, 2020 94.52%
Jun 30, 2020 -54.09%
Mar 31, 2020 -465.10%
Dec 31, 2019 -103.57%
Sep 30, 2019 -15.41%
Jun 30, 2019 329.63%
Mar 31, 2019 107.63%
Dec 31, 2018 208.20%
Sep 30, 2018 -159.35%
Jun 30, 2018 109.05%
Mar 31, 2018 -46.00%
Dec 31, 2017 120.11%
Sep 30, 2017 87.43%
Jun 30, 2017 86.41%
Mar 31, 2017 -57.46%
Dec 31, 2016 -4,313.22%
Sep 30, 2016 30.23%
Jun 30, 2016 -336.28%
Mar 31, 2016 149.43%
Dec 31, 2015 96.62%
Sep 30, 2015 -280.06%
Jun 30, 2015 -19.64%
Mar 31, 2015 5.05%
Dec 31, 2014 -853.61%
Sep 30, 2014 19.98%
Jun 30, 2014 -32.07%
Mar 31, 2014 4.06%
Dec 31, 2013 109.58%
Sep 30, 2013 44.92%
Jun 30, 2013 33.79%
Mar 31, 2013 22.37%
Dec 31, 2012 -217.38%
Sep 30, 2012 -49.22%
Jun 30, 2012 32.72%
Mar 31, 2012 -84.99%
Dec 31, 2011 62.13%
Sep 30, 2011 -5.53%